Bioprocess Technology Market Outlook & Regional Analysis 2030

Overview:

The bioprocess technology market share is expected to reach USD 19.84 Billion by 2032 at 7.1% CAGR during the forecast period 2023-2032.

Bioprocess Technology Market Size is witnessing at present an unprecedented growth due to revolutionary changes effected upon it by technological advancements. The impact is aptly backed by demands generated by the healthcare sector. The global Bioprocess Technology market is expected to witness significant growth during the forecast period (2017-2022), reveals Market Research Future (MRFR) in a detailed analysis of the said market. Bioprocess Technology involves deriving living cells or components and obtains desired results to boost pharmaceuticals or chemical sector. The report incorporates multiple factors that can promote Bioprocess Technology market further such as its growing use in developing new drugs & treatments, food processing, thermal design of biomedical devices, and effective application in pollution control & global warming. An in-depth review of the segments has also been included for a better understanding of the bioprocess technology consultants market in coming years.

However, the regulatory process often delays the approval of new drugs which can increase the production cost by a significant margin. This can put a leash on the expected Bioprocess Technology Market Share, growth during the forecast period.

Bioprocess Technology Market Overview and Information, by Type (flow cytometry, cell culture, cell expansion, cell line development, virus infiltration), by Application (biopharmaceuticals, specialty products and industrial chemicals, environmental management aid), by End Users (hospitals, research Centers, medical institutions)

Key Players:

Some of the Bioprocess Technology Market Players profiled in this report are

Merck Millipore (Germany),

Thermo Fisher Scientific, Inc. (U.S.),

Becton,

Dickinson and Company (U.S.),

Danaher Corporation (U.S.),

Lonza Group AG (Switzerland),

Sartorius Stedim Biotech S.A (France),

Corning, Inc. (U.S.),

Bio-Rad Laboratories (U.S.),

Charles River Laboratories (U.S.), and

others.    

Segmentation:

The global Bioprocess Technology Market Outlook can be segmented by type, application, and end-users.

• Type-based segmentation of the Bioprocess Technology market includes cell culture, cell expansion, flow cytometry, cell line development, and virus infiltration. Cell culture has diverse application in various sectors which gives it much traction, and it has become a necessary part in treating chronic diseases.
• Application-wise, the Bioprocess Technology market comprises biopharmaceuticals, specialty products, industrial chemicals, and environment management aid. Biopharmaceuticals’ prosperous run is to continue owing to its widespread functioning area as it has impacted common medicines to chronic diseases. Furthermore, petrochemicals can propel the demand for industrial chemicals in coming
• Based on end-users, the Bioprocess Technology market consists hospitals, research labs and centers, medical institutions and others. Research labs and centers to gain the most owing to private and government investments in the field.

Regional Analysis:

Region-specific analysis of the Bioprocess Technology Market Insights Report includes North America, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).

North America’s growth can be attributed to its ability to fetch the maximum revenue in the global market. Infrastructural superiority can be considered as a boon for the regional market. Furthermore, healthcare is receiving much funding which is directly impacting the Bioprocess Technology market by generating demand for pharmaceutical drugs. Governments and private investors are also spending much in search for new Bioprocess Technology-based products. 

Europe is also drawing significant attention from the global market by providing excellent infrastructure for research and development in this sector. However, the APAC is the fastest growing region and is touted to influence the market considerably in coming years. Growing population and revamped healthcare sector can provide the much-needed thrust to the regional market.

Market Insight:

Strategies employed by the bigshots in the sector help in both individual and holistic growth of the Bioprocess Technology market. These strategies include mergers, acquisitions, product launch, and other methods and better the market portfolio of companies. For instance, Charles River Laboratories has recently acquired MPI Research, a non-clinical contract research organization (CRO) that provides testing services to biopharmaceutical and medical device companies across the globe. Their market rival, Thermo Fisher Scientific, Inc. signed an agreement with Roper Technologies to acquire Gatan, which can ensure their market profile upgradation.

Industry News:

• Novartis and Gilead/Kite have got approval for their respective medicines Kymriah and Yescarta, two cell-therapy biotherapeutic medicine which can significantly trigger monoclonal antibody industry prospect.

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

Bioprocess Technology Market Insights To Witness Notable Growth During the Forecast Period 2022-2030

 

Market Scenario

The bioprocess technology market size is expected to reach USD 17,300 Million by 2030 at 7.1% CAGR during the forecast period 2022-2030. Bioprocess technology is a specific process in which complete living cells or their components (e.g. enzymes, bacteria, chloroplasts) are use to obtain desired products. It deals with development and designing of equipment and processes for the manufacturing of products such as pharmaceuticals, chemicals, nutraceuticals, agriculture, papers and polymers from biological materials for treatment of waste water. Increase in the demand of fermenters using for large scaler manufacturing and producing large amount of end products has great demand of bioprocess technology. New fermentation technology, microorganism and enzymes gives different taste and texture to the food prolonging their shelf life and more palatable and digestible has increased the demand for bioprocessing market. In agriculture field bioprocessing is in greater demand it provides scientists new ways to develop more nutritious crop varieties, higher yield, disease resistance crops which results in reduce the need of fertilizers and other expensive agriculture chemicals.

The increase in the demand for stem cell conservation and regenerative medicine, Bio medical engineering, Cancer therapy, Biotechnology in textile industry are major driving factors for bio process technology. According to Charloote Lozier Institute in 2014 nearly 20,000 adult stem cell transplants were performed in United States. Also for the patient suffering for multiple myeloma more than 30,000 bone marrow and umbilical cord transplantation were done from 2010 to 2014 which can promote to grow in forecasted year which will result in enhancing the bioprocessing technology market. According to India brand equity foundation organization (IBEF) Department of Industrial Policies and Promotion (DIPP), has stated that Indian food processing sector has reached around US$ 7.56 billion worth to Foreign Direct Investment (FDI) during the period of April 2000 to March 2017. Confederation of Indian Industry (CII) estimates that the food processing sector can reach US$ 33 billion of investment in come 10 years. National Institute of Biomedical Imaging and Bioengineering published that tissue engineering (Artificial skin and cartilage) and regenerative medicine, is a field which focuses on cures instead of treatment for complex or chronic diseases has a greater demand. Scaffold for regenerating new kidney, engineering mature bone stem cell use to treat genetic diseases. Additionally, innovation in product offering are likely to boost the bioprocess technology equipment. However, cost incurred in is technology, cost for new product development, societal concerns lower the growth of bioprocess technology market. 

Bio-process Market-Competitive Landscape

The global bio process technology market insights is characterized by the presence of several well-established and small players, the market appears to be highly competitive and fragmented. Multinational players are increasingly expanding their regional footprint in the developing economy, making it difficult for regional vendors to compete with them, especially in terms of features such as product differentiation, diverse product portfolios, and quality. The well-established market players are engaged in strategic acquisitions, collaborations, partnerships, global expansion, and product launches to gain competitive advantage in this market and to maintain their market position. Global bio process technology market players are Merck Millipore (Germany), Thermo Fisher Scientific, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Danaher Corporation (U.S.), Lonza Group AG (Switzerland), Sartorius Stedim Biotech S.A (France), Corning, Inc. (U.S.), GE healthcare(US), Catalent (US), Boehringer Inelheim (Germany), Bio-Rad Laboratories (U.S.), and Charles River Laboratories (U.S.), Serum Institute of India are some Prominent players in the market.

Regional Analysis

The American region is expected to be the leading region in the global digestible sensors market owing to presence of advanced technology and well-developed healthcare sector. On regional basis, American region is divided into North America and South America. North America dominates the market due to presence of developed countries like the US and high disposable income. Americas held the largest share of the medical bioprocess technology market. According, to NCBI U.S lead in process validation and Food and Drug Administration (FDA) which promotes the market in this region.

Europe is anticipated to be the second largest market for Bioprocess technology. According to National center of Biotechnology Information (NCBI) biotechnology product have grown approximately $100 million a year to $4 billion a year and expected to grow in coming years.

Asia-Pacific is expected to be the fastest growing market for the Bioprocessing  market during the forecast period. According to National center of Biotechnology Information Japan leads the market both in upstream and downstream processing.

Furthermore, the Middle East and Africa region holds the lowest market share. The market in the Middle.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America